GlassScriptPhysician profile
Sydney Chung
NPI 1013554922
$911.81
in general payments reported to CMS, 2019-2025
14 companies · $41.25 in 2025
The $41.25 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $738 · 2022: $23.53 · 2023: $38.20 · 2024: $70.38 · 2025: $41.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $259.92 | 2021 | |
| Nestle Healthcare Nutrition INC. | $179.39 | 2021 | |
| Boston Scientific Corporation | $124.62 | 2021 | |
| Glaxosmithkline, LLC. | $121.83 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.76 | 2021 | |
| Becton, Dickinson and Company | $26.76 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $26.37 | 2024 | Pico 14 |
| Immunocore Limited | $23.53 | 2022 | |
| Medtronic, INC. | $22.82 | 2025 | Aquamantys(Tm) |
| Genentech USA, INC. | $19.30 | 2023 | Phesgo |
| Kyowa Kirin, INC. | $18.90 | 2023 | Poteligeo |
| Eisai INC. | $18.43 | 2025 | |
| Abbvie INC. | $17.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.